FOLD logo

Amicus Therapeutics, Inc. (FOLD) Cash From Investing

Annual CFI:

-$560.00K-$98.62M(-100.57%)
December 31, 2024

Summary

  • As of today, FOLD annual cash from investing is -$560.00 thousand, with the most recent change of -$98.62 million (-100.57%) on December 31, 2024.
  • During the last 3 years, FOLD annual cash from investing has fallen by -$79.32 million (-100.71%).
  • FOLD annual cash from investing is now -100.57% below its all-time high of $98.06 million, reached on December 31, 2023.

Performance

FOLD Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

Quarterly CFI:

-$5.78M+$27.08M(+82.42%)
June 30, 2025

Summary

  • As of today, FOLD quarterly cash from investing is -$5.78 million, with the most recent change of +$27.08 million (+82.42%) on June 30, 2025.
  • Over the past year, FOLD quarterly cash from investing has increased by +$16.20 million (+73.71%).
  • FOLD quarterly cash from investing is now -105.05% below its all-time high of $114.48 million, reached on September 30, 2018.

Performance

FOLD Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

TTM CFI:

-$24.76M+$16.20M(+39.55%)
June 30, 2025

Summary

  • As of today, FOLD TTM cash from investing is -$24.76 million, with the most recent change of +$16.20 million (+39.55%) on June 30, 2025.
  • Over the past year, FOLD TTM cash from investing has dropped by -$22.13 million (-840.69%).
  • FOLD TTM cash from investing is now -112.80% below its all-time high of $193.41 million, reached on June 30, 2020.

Performance

FOLD TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

FOLD Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-100.6%+73.7%-840.7%
3Y3 Years-100.7%-122.0%-148.6%
5Y5 Years-100.6%-108.3%-168.5%

FOLD Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.6%at low-107.8%+91.3%-125.3%+39.5%
5Y5-Year-100.6%+95.9%-106.7%+96.3%-120.0%+61.6%
All-TimeAll-Time-100.6%+99.7%-105.0%+97.8%-112.8%+92.0%

FOLD Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$5.78M(+82.4%)
-$24.76M(+39.6%)
Mar 2025
-
-$32.86M(-61.1%)
-$40.96M(-7213.9%)
Dec 2024
-$560.00K(-100.6%)
-$20.39M(-159.5%)
-$560.00K(+86.4%)
Sep 2024
-
$34.27M(+255.9%)
-$4.13M(-56.7%)
Jun 2024
-
-$21.98M(-391.6%)
-$2.63M(-103.8%)
Mar 2024
-
$7.54M(+131.5%)
$69.35M(-29.3%)
Dec 2023
$98.06M(+6.2%)
-$23.96M(-167.0%)
$98.06M(+77.3%)
Sep 2023
-
$35.77M(-28.5%)
$55.32M(-41.2%)
Jun 2023
-
$50.00M(+37.9%)
$94.07M(+33.7%)
Mar 2023
-
$36.26M(+154.4%)
$70.36M(-23.8%)
Dec 2022
$92.32M(+17.2%)
-$66.70M(-189.5%)
$92.32M(+1.5%)
Sep 2022
-
$74.52M(+183.4%)
$90.93M(+78.3%)
Jun 2022
-
$26.29M(-54.8%)
$50.99M(+1.1%)
Mar 2022
-
$58.21M(+185.5%)
$50.41M(-36.0%)
Dec 2021
$78.76M(+680.0%)
-$68.09M(-296.9%)
$78.76M(-36.5%)
Sep 2021
-
$34.57M(+34.5%)
$124.07M(+292.2%)
Jun 2021
-
$25.71M(-70.3%)
-$64.56M(-218.7%)
Mar 2021
-
$86.56M(+480.1%)
-$20.26M(-49.2%)
Dec 2020
-$13.58M(-114.3%)
-$22.78M(+85.2%)
-$13.58M(-137.6%)
Sep 2020
-
-$154.06M(-320.0%)
$36.16M(-81.3%)
Jun 2020
-
$70.01M(-24.9%)
$193.41M(+78.5%)
Mar 2020
-
$93.25M(+245.8%)
$108.33M(+13.9%)
Dec 2019
$95.15M(+178.5%)
$26.96M(+744.4%)
$95.15M(+2068.0%)
Sep 2019
-
$3.19M(+121.2%)
$4.39M(-96.2%)
Jun 2019
-
-$15.07M(-118.8%)
$115.67M(-18.2%)
Mar 2019
-
$80.06M(+225.5%)
$141.47M(+216.7%)
Dec 2018
-$121.20M(+29.2%)
-$63.80M(-155.7%)
-$121.20M(-1966.5%)
Sep 2018
-
$114.48M(+967.2%)
-$5.87M(+98.0%)
Jun 2018
-
$10.73M(+105.9%)
-$294.25M(-12.6%)
Mar 2018
-
-$182.60M(-454.3%)
-$261.43M(-52.7%)
Dec 2017
-$171.24M(-3697.8%)
$51.53M(+129.6%)
-$171.24M(+8.6%)
Sep 2017
-
-$173.91M(-499.4%)
-$187.43M(-334.5%)
Jun 2017
-
$43.55M(+147.1%)
-$43.13M(+55.3%)
Mar 2017
-
-$92.41M(-361.5%)
-$96.48M(-2039.7%)
Dec 2016
-$4.51M(+96.9%)
$35.34M(+219.3%)
-$4.51M(-109.9%)
Sep 2016
-
-$29.61M(-202.3%)
$45.55M(+124.4%)
Jun 2016
-
-$9.80M(-2116.5%)
-$186.90M(-11.6%)
Mar 2016
-
-$442.00K(-100.5%)
-$167.45M(-15.2%)
Dec 2015
-$145.34M
$85.41M(+132.6%)
-$145.34M(+53.2%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$262.07M(-2814.3%)
-$310.48M(-298.6%)
Jun 2015
-
$9.65M(-55.4%)
-$77.89M(+2.2%)
Mar 2015
-
$21.66M(+127.2%)
-$79.61M(+25.7%)
Dec 2014
-$107.08M(-510.5%)
-$79.73M(-170.5%)
-$107.08M(-203.3%)
Sep 2014
-
-$29.48M(-471.5%)
-$35.31M(-346.0%)
Jun 2014
-
$7.93M(+236.8%)
$14.35M(+6.2%)
Mar 2014
-
-$5.80M(+27.2%)
$13.52M(-48.2%)
Dec 2013
$26.08M(+166.1%)
-$7.97M(-139.5%)
$26.08M(-48.5%)
Sep 2013
-
$20.18M(+184.3%)
$50.66M(+232.4%)
Jun 2013
-
$7.10M(+5.0%)
$15.24M(-36.6%)
Mar 2013
-
$6.76M(-59.3%)
$24.02M(+160.9%)
Dec 2012
-$39.43M(-184.9%)
$16.61M(+209.0%)
-$39.43M(+2.3%)
Sep 2012
-
-$15.24M(-195.9%)
-$40.35M(-172.6%)
Jun 2012
-
$15.88M(+128.0%)
-$14.80M(+32.6%)
Mar 2012
-
-$56.69M(-461.3%)
-$21.95M(-147.3%)
Dec 2011
$46.45M(+338.9%)
$15.69M(+52.2%)
$46.45M(+491.8%)
Sep 2011
-
$10.31M(+18.1%)
-$11.86M(+10.6%)
Jun 2011
-
$8.73M(-25.5%)
-$13.26M(+28.8%)
Mar 2011
-
$11.72M(+127.5%)
-$18.63M(+4.2%)
Dec 2010
-$19.44M(-161.0%)
-$42.62M(-578.3%)
-$19.44M(-159.0%)
Sep 2010
-
$8.91M(+165.0%)
$32.95M(-16.8%)
Jun 2010
-
$3.36M(-69.2%)
$39.58M(+8.5%)
Mar 2010
-
$10.90M(+11.6%)
$36.49M(+14.5%)
Dec 2009
$31.87M(+46.5%)
$9.77M(-37.1%)
$31.87M(-29.0%)
Sep 2009
-
$15.54M(+5614.7%)
$44.91M(+0.4%)
Jun 2009
-
$272.00K(-95.7%)
$44.74M(-4.2%)
Mar 2009
-
$6.28M(-72.5%)
$46.68M(+114.7%)
Dec 2008
$21.75M(+129.0%)
$22.81M(+48.3%)
$21.75M(+214.9%)
Sep 2008
-
$15.38M(+596.0%)
-$18.93M(+45.2%)
Jun 2008
-
$2.21M(+111.8%)
-$34.52M(+60.9%)
Mar 2008
-
-$18.66M(-4.4%)
-$88.21M(-17.6%)
Dec 2007
-$75.04M(-182.1%)
-$17.87M(-8615.1%)
-$75.04M(-31.2%)
Sep 2007
-
-$205.00K(+99.6%)
-$57.18M(-0.4%)
Jun 2007
-
-$51.49M(-839.0%)
-$56.97M(-939.0%)
Mar 2007
-
-$5.48M
-$5.48M
Dec 2006
-$26.60M(-57.1%)
-
-
Dec 2005
-$16.94M(-282.5%)
-
-
Dec 2004
-$4.43M(-305.1%)
-
-
Dec 2003
-$1.09M
-
-

FAQ

  • What is Amicus Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Amicus Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Amicus Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of FOLD is -$560.00K

What is the all-time high annual cash from investing for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual cash from investing is $98.06M

What is Amicus Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, FOLD annual cash from investing has changed by -$98.62M (-100.57%)

What is Amicus Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of FOLD is -$5.78M

What is the all-time high quarterly cash from investing for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly cash from investing is $114.48M

What is Amicus Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, FOLD quarterly cash from investing has changed by +$16.20M (+73.71%)

What is Amicus Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of FOLD is -$24.76M

What is the all-time high TTM cash from investing for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high TTM cash from investing is $193.41M

What is Amicus Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, FOLD TTM cash from investing has changed by -$22.13M (-840.69%)
On this page